Back to Search
Start Over
First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival.
- Source :
-
Blood [Blood] 2018 Jan 18; Vol. 131 (3), pp. 368-371. Date of Electronic Publication: 2017 Nov 27. - Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 1528-0020
- Volume :
- 131
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Editorial & Opinion
- Accession number :
- 29180400
- Full Text :
- https://doi.org/10.1182/blood-2017-09-806463